Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Jianming Ying

ResearcherPublications, citations & collaboration network

Jianming Ying is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 506 works, 10,031 citations, an h-index of 54 and an i10-index of 185.

506
Works
10,031
Citations
54
h-index
185
i10-index

How has Jianming Ying's publication output changed over time?

ScholarIQpublication output · 2005–2022

Output grew0% over the shown period — from 2 works in 2005 to 2 in 2022.

2
1
1
2
4
2
200520072008201820202022

What are the most-cited papers on Jianming Ying?

ScholarIQmost cited works
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Shugeng Gao, Ning Li, Shun‐Yu Gao, Qi Xue, Jianming Ying, Shuhang Wang, Xiuli Tao, Jun Zhao, Yousheng Mao, Bing Wang, Kang Shao, Wendong Lei, Dali Wang, Fang Lv, Liang Zhao, Fan Zhang, Ziran Zhao, Kai Su, Fengwei Tan, Yibo Gao, Nan Sun, Dawei Wu, Yue Yu, Yun Ling, Zhijie Wang, Chunjian Duan, Wei Tang, Lei Zhang, Shun He, Ning Wu, Jie Wang, Jie He
Journal of Thoracic Oncology. 2020418 CitationsOPEN ACCESS
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Xinan Sheng, Xieqiao Yan, Lin Wang, Yanxia Shi, Xin Yao, Hong Luo, Benkang Shi, Jiyan Liu, Zhisong He, Guohua Yu, Jianming Ying, Weiqing Han, Chang-Lu Hu, Yun Ling, Zhihong Chi, Chuanliang Cui, Lu Si, Jianmin Fang, Aiping Zhou, Jun Guo
Clinical Cancer Research. 2020285 CitationsOPEN ACCESS
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
Jianming Ying, H Li, T J Seng, Cordelia Langford, Gopesh Srivastava, Sai Wah Tsao, Thomas Choudary Putti, Paul G. Murray, Anthony T.�C. Chan, Qian Tao
S128439998. 2005284 Citations
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Lei Yang, Di Dong, Mengjie Fang, Yongbei Zhu, Yali Zang, Zhenyu Liu, Hongmei Zhang, Jianming Ying, Xinming Zhao, Jie Tian
European Radiology. 2018252 Citations
DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function
Bilian Jin, Qian Tao, Jinrong Peng, Hui Meng Soo, Wei Wu, Jianming Ying, C. Robert Fields, Amber L. Delmas, Xuefeng Liu, Jingxin Qiu, Keith D. Robertson
S166515463. 2007236 CitationsOPEN ACCESS

Related on ScholarIQ

Beijing Institute of Technology
Institution
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Paper
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Paper
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
Paper
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Paper
DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function
Paper
470M+ articles · free account